{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:51:28Z","timestamp":1787007088637,"version":"build-2736575974"},"reference-count":129,"publisher":"Informa UK Limited","issue":"3","funder":[{"name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento Pessoal de N\u00edvel Superior-Brasil","award":["001"],"award-info":[{"award-number":["001"]}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"crossref","award":["FAPERJ"],"award-info":[{"award-number":["FAPERJ"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"crossref","award":["Ed. 15\/2015-2022"],"award-info":[{"award-number":["Ed. 15\/2015-2022"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"crossref","award":["MCTI-CNPq"],"award-info":[{"award-number":["MCTI-CNPq"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"crossref","award":["Universal 14\/2016-2022"],"award-info":[{"award-number":["Universal 14\/2016-2022"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Therapeutic Patents"],"published-print":{"date-parts":[[2023,3,4]]},"DOI":"10.1080\/13543776.2023.2176219","type":"journal-article","created":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T04:21:07Z","timestamp":1676348467000},"page":"193-209","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":5,"title":["Are patents important indicators of innovation for Chagas disease treatment?"],"prefix":"10.1080","volume":"33","author":[{"given":"Andrea Pestana","family":"Caroli","sequence":"first","affiliation":[{"name":"Federal University of Rio de Janeiro (UFRJ), Institute of Microbiology Paulo de G\u00f3es, BIOINOVAR - Biocatalysis, Bioproducts and Bioenergy, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe R. P.","family":"Mansoldo","sequence":"additional","affiliation":[{"name":"Federal University of Rio de Janeiro (UFRJ), Institute of Microbiology Paulo de G\u00f3es, BIOINOVAR - Biocatalysis, Bioproducts and Bioenergy, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica S.","family":"Cardoso","sequence":"additional","affiliation":[{"name":"Federal University of Rio de Janeiro (UFRJ), Institute of Microbiology Paulo de G\u00f3es, BIOINOVAR - Biocatalysis, Bioproducts and Bioenergy, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celso Luiz Salgueiro","family":"Lage","sequence":"additional","affiliation":[{"name":"National Institute of Intellectual Property (INPI), Graduate and Research Division, Rio de Janeiro-RJ, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia L.","family":"Carmo","sequence":"additional","affiliation":[{"name":"Federal University of Rio de Janeiro (UFRJ), Institute of Microbiology Paulo de G\u00f3es, LEMM - Molecular Microbial Ecology Laboratory"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiu T","family":"Supuran","sequence":"additional","affiliation":[{"name":"NEUROFARBA Department Sezione di Scienze Farmaceutiche, Universit\u00e0 degli Studi di Firenze, Sesto Fiorentino (Florence), Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5926-4172","authenticated-orcid":false,"given":"Alane","family":"Beatriz Vermelho","sequence":"additional","affiliation":[{"name":"Federal University of Rio de Janeiro (UFRJ), Institute of Microbiology Paulo de G\u00f3es, BIOINOVAR - Biocatalysis, Bioproducts and Bioenergy, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,2,15]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1177\/20499361211033715"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1016\/j.actatropica.2021.106219"},{"key":"cit0003","unstructured":"MSF. Overcoming neglect: finding ways to manage and control NTDs. 2022 [cited 2022 Aug 3]. Available from: https:\/\/www.msf.org\/overcoming-neglect-report-ntds."},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1590\/0074-0276140236"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1007\/s40475-020-00225-y"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00152-21"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2019.00166"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0009954"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00023-19"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-013-0613-y"},{"issue":"3","key":"cit0011","volume":"6","author":"Rodea GB","year":"2018","journal-title":"J Microbiol Exp"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12112752"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2022.102284"},{"key":"cit0014","first-page":"e0171","volume":"55","author":"As de S","year":"2022","journal-title":"Rev Soc Bras Med Trop"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.17-0516"},{"key":"cit0016","unstructured":"DNDi. Chagas disease facts. 2022. [cited 2022 Jun 10]. Available from: https:\/\/dndi.org\/diseases\/chagas\/facts."},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112020"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis331"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.926699"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30844-6"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.12.023"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1313122"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0000000000000192"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30535-2"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001870"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02754-13"},{"key":"cit0027","unstructured":"DNDi. Fexinidazole for Chagas. 2013. [cited 2022 Jun 10]. Available from: https:\/\/dndi.org\/research-development\/portfolio\/fexinidazole-chagas\/."},{"issue":"3","key":"cit0028","first-page":"ciac579","volume":"76","author":"Torrico F","year":"2022","journal-title":"Clin Infect Dis"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2020.630888"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1038\/nature19339"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1080\/17460441.2020.1681394"},{"key":"cit0032","unstructured":"Maldonado RA, Vasquez MA, Dimmock JR, et al. Antiparasitic effect of bis[3,5-bis(benzylidene)-4-oxo-1-piperidinyl]amide derivatives. US2016303105A1. 2016."},{"key":"cit0033","unstructured":"Escario G-TJA, Gomez BA, Nogal RJJ, et al. Amines derived from 2-benzyl-5-nitroindazole with antiprotozoal properties against Trypanosoma, leishmania and trichomonas. WO2019077174A1. 2019."},{"key":"cit0034","unstructured":"De OJVX, Pedron CN, Freire KA, et al. Antiprotozoal peptides derived from scorpion venom, nucleic acid molecule encoding same, composition comprising same, and uses thereof. WO2020237334A1. 2020."},{"key":"cit0035","unstructured":"Fanny P-B, Kerly FMP, Leoberto CT. compostos azomet\u00ednicos derivados do 5-nitrofurano e uso. BR102018000642A2. 2019."},{"key":"cit0036","unstructured":"Iara RS, Policarpo ASJ, Renata BDO, et al. composi\u00e7\u00f5es farmat\u00eauticas tripanocidas e uso. BR102019010132A2. 2020."},{"key":"cit0037","unstructured":"Ribas SX, Costas SM, Cusso FO, et al. Metal complexes comprising polyamine compounds and said compounds for use as antiparasitic agents. ES2440896A1. 2014."},{"key":"cit0038","unstructured":"Thompson AM, Denny WA, Blaser A, et al. Nitroimidazooxazine analogues and their uses. EP2459570A1. 2012."},{"key":"cit0039","unstructured":"Ihara M, Ge J-F, Arai C, et al. Medicinal composition containing benzo[a]phenoxanthin compound as the active ingredient for preventing or treating protozoal disease. EP2269996A1. 2011."},{"key":"cit0040","unstructured":"Ferreira AMDC, Sabino GL, Paula QAD, et al. Complexos met\u00e1licos com ligantes ind\u00f3licos ou oxind\u00f3licos e seus derivados im\u00ednicos e seu uso como agentes antiparasit\u00e1rios. BR102013026558A2. 2015."},{"key":"cit0041","unstructured":"Lidia ML, Eliezer JDLB, Marina AA. Hydrazide-N-acylhydrazone compounds, method for producing hydrazide-n-acylhydrazone compounds, use of intermediate compounds for producing hydrazide-N-acylhydrazones for the treatment of leishmaniasis and Chagas disease, and thus obtained pharmaceutical compositions. WO2014019044A1. 2014."},{"key":"cit0042","unstructured":"Wischik CM, Storey JMD, Marshall C, et al. Methods of synthesis and\/or purification of diaminophenothiazinium compounds. EP3121169A1. 2017."},{"key":"cit0043","unstructured":"Thomas S, Hopper AT, Welsch M. Compositions and methods for treating infections. EP3411367A1. 2018."},{"key":"cit0044","unstructured":"Bakare O, Lee CM, Brandy Y, et al. Method for inhibiting\n                      Trypanosoma cruzi\n                      . US2015073177A1. 2015."},{"key":"cit0045","unstructured":"Rivera S\u00e1nchez GILDARDO, Nogueda Torres BENJAM\u00cdN, Edgar Eduardo LARARAM\u00cdREZ, et al. Use of ketanserin tartrate for the treatment of Chagas disease as an anti-\n                      Trypanosoma cruzi\n                      agent. MX; MX 2016017185 A. 2018. Available from: https:\/\/lens.org\/039-960-260-143-774."},{"key":"cit0046","unstructured":"Rivera S\u00e1nchez GILDARDO, Nogueda Torres BENJAM\u00cdN, Edgar Eduardo LARARAM\u00cdREZ, et al. use of etofylline clofibrate for the treatment of Chagas disease as an anti-\n                      Trypanosoma cruzi\n                      agent. MX; MX 2016017186 A. 2018. Available from: https:\/\/lens.org\/116-938-360-752-550."},{"key":"cit0047","unstructured":"Rivera S\u00e1nchez GILDARDO, Nogueda Torres BENJAM\u00cdN. Edgar eduardo lara ram\u00edrez, et al. use of sodium piperacillin for the treatment of Chagas disease as an anti-\n                      Trypanosoma cruzi\n                      agent. MX; MX 2016017182 A. 2018. Available from: https:\/\/lens.org\/192-503-972-641-943."},{"key":"cit0048","unstructured":"Rivera S\u00e1nchez GILDARDO, Nogueda Torres BENJAM\u00cdN, Edgar Eduardo LARARAM\u00cdREZ, et al. Use of doxazosin mesylate for the treatment of Chagas disease as an anti-\n                      Trypanosoma cruzi\n                      agent. MX; MX 2016017183 A. 2018. Available from: https:\/\/lens.org\/098-531-817-092-340."},{"key":"cit0049","unstructured":"Rivera S\u00e1nchez GILDARDO, Nogueda Torres BENJAM\u00cdN, Edgar Eduardo LARARAM\u00cdREZ, et al. Use of sulfasalazine for the treatment of Chagas disease as an anti-\n                      Trypanosoma cruzi\n                      agent. MX; MX 2016017197 A. 2018. Available from: https:\/\/lens.org\/093-774-853-711-385."},{"key":"cit0050","unstructured":"Ang SH, Krastel P, Leong SY, et al. Spiro-Indole Derivatives for the Treatment of Parasitic Diseases. EP2285808A1. 2011."},{"key":"cit0051","unstructured":"Gildardo RS, Benjam\u00edn NT, Edgar ELR, et al. Use of terfenadine for the treatment of Chagas disease as anti-\n                      Trypanosoma cruzi\n                      agent. MX2016016018A. 2018."},{"key":"cit0052","unstructured":"Cao Y, Jiang S, Kim H, et al. Solid Forms of N-(4-Fluoro-3-(6-(3-Methylpyridin-2-Yl)-[1,2,4]triazolo[1,5-A]pyrimidin-2-Yl)phenyl)-2,4-Dimethyloxazole-5-Carboxamide. EP3864018A1. 2021."},{"key":"cit0053","unstructured":"D\u2019antonio E, Pierce J. One-Step Synthesis of Phosphate-Based Inhibitors and Applications Thereof. US2021130381A1. 2021."},{"key":"cit0054","unstructured":"Costi MP, Costantino L, Ferrari S, et al. Triaminopyrimidine derivatives with antiparasitic activity. WO2020188437A1. 2020."},{"key":"cit0055","unstructured":"Isabel E, Mellon C, Beaulieu C. Cysteine protease inhibitors for the treatment of parasitic diseases. EP2225196A1. 2010."},{"key":"cit0056","unstructured":"Quibell M. Inhibitors of cruzipain and other cysteine proteases. US2009247471A1. 2009."},{"key":"cit0057","doi-asserted-by":"publisher","DOI":"10.33448\/rsd-v11i3.26531"},{"key":"cit0058","unstructured":"Galdino SL, Moreira TLDB, De CTMU, et al. Imidazolidine and thiazolidine molecules with anti-\n                      T. cruzi\n                      activity. WO2012119212A1. 2012."},{"key":"cit0059","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2007.12.049"},{"key":"cit0060","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2017.02.009"},{"key":"cit0061","unstructured":"Brand S, Dodd P, Ko EJ, et al. Compounds. EP3331885A1. 2018."},{"key":"cit0062","unstructured":"Gildardo RS, Benjam\u00edn NT, Edgar ELR, et al. Use of the sodium cefoperazone for the treatment of Chagas disease as an anti-\n                      Trypanosoma cruzi\n                      agent. MX2016017177A. 2018."},{"key":"cit0063","unstructured":"Gildardo RS, Benjam\u00edn NT, Edgar ELR, et al. Use of sodium flucloxacillin for the treatment of Chagas disease as an anti-\n                      Trypanosoma cruzi\n                      agent. MX2016017175A. 2018."},{"key":"cit0064","doi-asserted-by":"publisher","DOI":"10.3390\/molecules22061015"},{"key":"cit0065","unstructured":"Biggart A, Liang F, Mathison CJN, et al. [1,2,4]triazolo[1,5-A]pyrimidine derivatives as protozoan proteasome inhibitors for the treatment of parasitic diseases such as leishmaniasis. EP3083627A1. 2016."},{"key":"cit0066","unstructured":"Jiricek J, Lerario IK, Liang F, et al. 5,6-fused-bicyclic compounds and compositions for the treatment of parasitic diseases. EP3630771A1. 2020."},{"key":"cit0067","doi-asserted-by":"publisher","DOI":"10.1111\/jeu.12896"},{"key":"cit0068","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-10292-3"},{"key":"cit0069","doi-asserted-by":"publisher","DOI":"10.1007\/s12192-019-01018-7"},{"key":"cit0070","unstructured":"Haas J, Andrews SW, Jiang Y, et al. Substituted pyrazolo[1,5-A]pyrimidine compounds as trk kinase inhibitors. EP3372605A1. 2018."},{"key":"cit0071","unstructured":"D\u2019antonio EL. Inhibitors of glucose kinases, along with methods of their formation and use. US2018280404A1. 2018."},{"key":"cit0072","unstructured":"D\u2019antonio E. Monosaccharide amine and 3-nitro-2-phenyl-2H-chromene based inhibitors of glucose kinases. US2020339619A1. 2020."},{"key":"cit0073","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112692"},{"key":"cit0074","doi-asserted-by":"publisher","DOI":"10.1080\/00034983.1982.11687544"},{"key":"cit0075","unstructured":"Andrews SW, Haas J, Jiang Y, et al. Method of treatment using substituted imidazo[1,2b]pyridazine compounds. US2017114068A1. 2017."},{"key":"cit0076","unstructured":"Brand S, Gaza EV, Gilbert I, et al. Imidazo[1,2-B][1,2,4]triazine derivatives as antiparasitic agents. US10065965B2. 2018."},{"key":"cit0077","unstructured":"DRUGS. Fexinidazole FDA Approval History. 2021 [cited 2022 Jul 7]. Available from: https:\/\/www.drugs.com\/history\/fexinidazole.html"},{"key":"cit0078","unstructured":"Ndsj E, Guilherme ADMJ, John FB, et al. 1,4-naftoquinonas substitu\u00eddas com atividade tripanocida, composi\u00e7\u00f5es farmac\u00eauticas tripanocidas e usos. BR102018008669A2. 2019."},{"key":"cit0079","doi-asserted-by":"publisher","DOI":"10.34117\/bjdv6n8-273"},{"key":"cit0080","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2012.03.039"},{"key":"cit0081","doi-asserted-by":"publisher","DOI":"10.5935\/0103-5053.20140180"},{"key":"cit0082","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.201200157"},{"key":"cit0083","doi-asserted-by":"publisher","DOI":"10.1039\/c2md20011b"},{"key":"cit0084","doi-asserted-by":"publisher","DOI":"10.1021\/jm4017015"},{"key":"cit0085","unstructured":"Rotger PMDC, Costa TA, S\u00e1nchez MM, et al. Antiparasitic activity of squaramide. WO2014184416A1. 2014."},{"key":"cit0086","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2019.01.033"},{"key":"cit0087","unstructured":"Roush WR, Choi JY, Podust L. Novel agents targeting Cyp51. WO2015048306A1. 2015."},{"key":"cit0088","doi-asserted-by":"publisher","DOI":"10.2147\/JEP.S267378"},{"key":"cit0089","unstructured":"Agnello S, Adams M, Kaiser M, et al. Antiprotozoal Compounds. EP3345917A1. 2018."},{"key":"cit0090","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.1c06347"},{"key":"cit0091","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00514-18"},{"key":"cit0092","unstructured":"Lautenschlager SDOS, Desoti VC, Nakamura CV, et al. Ascorbic acid and quinone compounds for treating Chagas disease. US2019343794A1. 2019."},{"key":"cit0093","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24173077"},{"key":"cit0094","doi-asserted-by":"publisher","DOI":"10.1007\/s00436-021-07137-4"},{"key":"cit0095","unstructured":"Alonso PJ, Charnley AK, Cotillo TI, et al. Benzothiazole derivative useful in the treatment of Chagas disease. WO2016055607A1. 2016."},{"key":"cit0096","doi-asserted-by":"publisher","DOI":"10.33448\/rsd-v9i10.9120"},{"key":"cit0097","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2021.114479"},{"key":"cit0098","volume-title":"Owning the sun: a people\u2019s history of monopoly medicine from aspirin to COVID-19 vaccines","author":"Zaitchik A","year":"2022"},{"key":"cit0099","doi-asserted-by":"publisher","DOI":"10.2174\/157489111796887864"},{"key":"cit0100","doi-asserted-by":"publisher","DOI":"10.2174\/157489107779561625"},{"key":"cit0101","doi-asserted-by":"publisher","DOI":"10.2174\/1574891X11666161024165304"},{"key":"cit0102","doi-asserted-by":"publisher","DOI":"10.1080\/13543776.2016.1209487"},{"key":"cit0103","doi-asserted-by":"publisher","DOI":"10.1186\/s12992-017-0306-9"},{"issue":"8","key":"cit0104","first-page":"81","volume":"20","author":"Chein Feres MV","year":"2018","journal-title":"Rev Direito Bras"},{"key":"cit0105","doi-asserted-by":"publisher","DOI":"10.4155\/ppa-2022-0005"},{"key":"cit0106","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25225483"},{"key":"cit0107","doi-asserted-by":"publisher","DOI":"10.1080\/13543776.2021.1970746"},{"key":"cit0108","doi-asserted-by":"publisher","DOI":"10.1007\/7355_2021_136"},{"key":"cit0109","doi-asserted-by":"publisher","DOI":"10.1007\/7355_2021_143"},{"key":"cit0110","doi-asserted-by":"publisher","DOI":"10.1080\/17460441.2021.1858794"},{"key":"cit0111","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(13)70078-0"},{"key":"cit0112","doi-asserted-by":"publisher","DOI":"10.1080\/17460441.2020.1704729"},{"key":"cit0113","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2019.05.005"},{"key":"cit0114","unstructured":"Novartis. World Chagas disease day 2021. 2022. [cited 2022 Jun 20]. Available from: https:\/\/www.novartis.com\/news\/world-chagas-disease-day-2021."},{"key":"cit0115","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14978"},{"key":"cit0116","doi-asserted-by":"publisher","DOI":"10.2174\/1574891X10666150410154322"},{"key":"cit0117","doi-asserted-by":"publisher","DOI":"10.1080\/01459740.2021.1946805"},{"key":"cit0118","doi-asserted-by":"publisher","DOI":"10.4324\/9780429266188-3"},{"key":"cit0119","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2020.1793955"},{"key":"cit0120","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1409077"},{"key":"cit0121","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.12355"},{"key":"cit0122","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30171-9"},{"key":"cit0123","doi-asserted-by":"publisher","DOI":"10.1038\/srep08771"},{"key":"cit0124","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.1c00047"},{"key":"cit0125","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1820175116"},{"key":"cit0126","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1010058"},{"key":"cit0127","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26154629"},{"key":"cit0128","volume-title":"New perspectives: neglected disease research and development","author":"G-FINDER","year":"2021"},{"key":"cit0129","unstructured":"Howard HR, Godek DM, Rodriguez S-M. Bicyclic antiparasitic compounds. US2019177304A1. 2019."}],"container-title":["Expert Opinion on Therapeutic Patents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543776.2023.2176219","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T10:15:50Z","timestamp":1683195350000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543776.2023.2176219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,15]]},"references-count":129,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3,4]]}},"alternative-id":["10.1080\/13543776.2023.2176219"],"URL":"https:\/\/doi.org\/10.1080\/13543776.2023.2176219","relation":{},"ISSN":["1354-3776","1744-7674"],"issn-type":[{"value":"1354-3776","type":"print"},{"value":"1744-7674","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,15]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-08-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-31","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}